ArticleBMC cardiovascular disorders2025
Association between urinary sodium excretion and all-cause mortality: a cohort study in a Chinese community-based population.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dietary sodium intake and all-cause mortality in rheumatoid arthritis: an NHANES analysis (2003-2018).Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe association between sodium intake and mortality risk in the general population remains controversial. We aimed to explore the association between sodium intake and all-cause mortality in a Chinese community-based population.
methodsA total of 6510 individuals from a Chinese community-based cohort were enrolled. 24-hour urinary sodium excretion was estimated using the Kawasaki formula. Cox proportional hazards models were used to determine the association of estimated urinary sodium excretion and spot urinary sodium with all-cause mortality.
resultsWith a mean follow-up of 3.13 years, 65 participants (1.0%) experienced all-cause mortality. The association between estimated urinary sodium excretion and all-cause mortality appeared to be J-shaped (P for non-linearity = 0.009). Individuals were grouped in quartiles according to estimated urinary sodium excretion and spot urinary sodium. After adjusting for risk factors, the fourth quartile of estimated urinary sodium excretion (> 5.75 g/day) was associated with an increased risk of mortality compared to the second quartile (3.90 to 4.76 g/day) (hazard ratio 2.94; 95% confidence interval, 1.27-6.83). Subgroup analyses revealed that current drinking status (P for interaction = 0.005) may serve as a potential modifying factor influencing the association between estimated urinary sodium excretion and all-cause mortality. There was no association between spot urinary sodium and all-cause mortality.
conclusionsHigher estimated urinary sodium excretion significantly increased all-cause mortality risk compared to moderate levels. Extremely low estimated urinary sodium excretion showed a similar trend. It is important for individuals with high sodium intake to reduce consumption to lower mortality risk. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.